Neurizon locks in global trademark protection across key pharma markets
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
Over 8.8?million Indians aged 60 and above currently live with dementia,
Favorable outcome would contribute to significantly containing the Roundup litigation as the company continues its multi-pronged strategy
The trial aims to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the combination therapy
CARsgen is working to transform outcomes for patients with solid tumors by advancing the potential of CAR T technologies
The study showed a statistically significant reduction in Valsalva left ventricular outflow tract (LVOT) gradient at Week 28 compared with placebo
Preclinical studies show that 4P004 modulates multiple biological markers across the joint, potentially slowing structural damage while improving function
Subscribe To Our Newsletter & Stay Updated